IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 34 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4,443,914 | $1,579,000 | 0.09% |
| CHELSEA COUNSEL CO | 28,000 | $10,000 | 0.00% |
| Ifrah Financial Services, Inc. | 18,500 | $7,000 | 0.00% |
| Gerstein Fisher | 13,000 | $5,000 | 0.00% |
| Renaissance Technologies | 1,407,200 | $500,000 | 0.00% |
| CITIGROUP INC | 31,700 | $11,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 19,012 | $7,000 | 0.00% |
| Catamount Wealth Management | 1,000 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 439,847 | $156,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 19,166 | $7,000 | 0.00% |